Guangzhou, China

Zhiqin Peng

This inventor holds 3 USPTO granted patents. Top assignees: Zhejiang Synsorbio Technology Co., Ltd., Guangzhou Reforgene Medicine Co., Ltd., Guangzhou Reforgene Medicine Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhiqin Peng. Retrieved from https://idiyas.com/inventor/zhiqin-peng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.3

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Zhiqin Peng: Innovator in Gene Editing Technologies

Introduction

Zhiqin Peng is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of gene editing, particularly through his innovative research and development efforts.

Latest Patents

Zhiqin Peng holds a patent for "Novel Cas Effector Proteins, Gene Editing Systems, and Uses Thereof." This patent represents a breakthrough in gene editing technologies, showcasing his expertise and commitment to advancing scientific knowledge.

Career Highlights

Zhiqin Peng is currently associated with Zhejiang Synsorbio Technology Co., Ltd. His work at this company has positioned him as a key player in the biotechnology sector, where he continues to push the boundaries of what is possible in gene editing.

Collaborations

He collaborates with talented individuals such as Hui Xu and Kaiwei Si, contributing to a dynamic research environment that fosters innovation and creativity.

Conclusion

Zhiqin Peng's contributions to gene editing and his innovative spirit make him a noteworthy figure in the field of biotechnology. His work continues to inspire future advancements in genetic research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…